0000899243-19-018360.txt : 20190627 0000899243-19-018360.hdr.sgml : 20190627 20190627161731 ACCESSION NUMBER: 0000899243-19-018360 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190617 FILED AS OF DATE: 20190627 DATE AS OF CHANGE: 20190627 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Krasnow Ronald A. CENTRAL INDEX KEY: 0001591469 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38356 FILM NUMBER: 19925505 MAIL ADDRESS: STREET 1: C/O RELYPSA, INC. STREET 2: 700 SAGINAW DR. CITY: REDWOOD CITY STATE: CA ZIP: 94063 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Menlo Therapeutics Inc. CENTRAL INDEX KEY: 0001566044 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 453757789 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 200 CARDINAL WAY, 2ND FLOOR CITY: REDWOOD CITY STATE: CA ZIP: 94063 BUSINESS PHONE: 650-486-1416 MAIL ADDRESS: STREET 1: 200 CARDINAL WAY, 2ND FLOOR CITY: REDWOOD CITY STATE: CA ZIP: 94063 FORMER COMPANY: FORMER CONFORMED NAME: Menlo Therapeutics, Inc. DATE OF NAME CHANGE: 20170728 FORMER COMPANY: FORMER CONFORMED NAME: Tigercat Pharma, Inc. DATE OF NAME CHANGE: 20130104 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-06-17 0 0001566044 Menlo Therapeutics Inc. MNLO 0001591469 Krasnow Ronald A. 200 CARDINAL WAY, 2ND FLOOR REDWOOD CITY CA 94063 0 1 0 0 See Remarks Stock Option 6.32 2019-06-17 4 A 0 130000 0.00 A 2029-06-17 Common Stock 130000 130000 D The shares subject to the option will vest over a period of four years, with 1/48th of the shares subject to the option vesting monthly. General Counsel and Chief Compliance Officer /s/ Ronald A. Krasnow 2019-06-27